Beijing Chieftain Control Engineering Technology Co., Ltd.(300430.SZ)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 764 | 915 | 974 | 1,176 | 958 | 470 | 502 | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 60 | 103 | 125 | 170 | 97 | -879 | -951 | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Beijing Chieftain Control Engineering Technology Co., Ltd. (BCCET), established in Beijing, China in 2003, specializes in the development, manufacturing, and sales of advanced automation systems for industrial production processes. The company primarily caters to the biological and pharmaceutical sectors within China. BCCET offers an extensive range of equipment, notably for powder processing, which includes dust-free crushing and pulse air mixing systems, automated lifting hopper mixers, dust-free feeding stations, ton bag unloaders, vacuum conveying solutions, precise metering and packing machines, CIP cleaning units, and auxiliary equipment such as dry granulators. Furthermore, their portfolio features sophisticated aseptic isolation technology, encompassing sterile isolation systems for packing and batching, restricted access barriers, negative pressure isolation units for operating environments, and reactor isolation feeding systems. The company also provides gas chloride sterilization apparatus and intelligent packing machinery. Beyond these, BCCET supplies a comprehensive array of specialized pharmaceutical and chemical equipment, covering processes like Chinese medicine extraction, evaporation concentration, purification and separation, fermentation preparation, distillation, and drying. Complementing their machinery, they also produce high-performance components such as diaphragm valves, globe valves, diaphragm globe valves, and other biomedical products, alongside professional medical pumps. These advanced solutions are widely applied across diverse industries, including pharmaceuticals, chemicals, food processing, additive manufacturing, power generation, and other industrial fields.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Beijing Chieftain Control Engineering Technology Co., Ltd. (300430.SZ)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Beijing Chieftain Control Engineering Technology Co., Ltd. (BCCET), established in Beijing, China in 2003, specializes in the development, manufacturing, and sales of advanced automation systems for industrial production processes. The company primarily caters to the biological and pharmaceutical sectors within China. BCCET offers an extensive range of equipment, notably for powder processing, which includes dust-free crushing and pulse air mixing systems, automated lifting hopper mixers, dust-free feeding stations, ton bag unloaders, vacuum conveying solutions, precise metering and packing machines, CIP cleaning units, and auxiliary equipment such as dry granulators. Furthermore, their portfolio features sophisticated aseptic isolation technology, encompassing sterile isolation systems for packing and batching, restricted access barriers, negative pressure isolation units for operating environments, and reactor isolation feeding systems. The company also provides gas chloride sterilization apparatus and intelligent packing machinery. Beyond these, BCCET supplies a comprehensive array of specialized pharmaceutical and chemical equipment, covering processes like Chinese medicine extraction, evaporation concentration, purification and separation, fermentation preparation, distillation, and drying. Complementing their machinery, they also produce high-performance components such as diaphragm valves, globe valves, diaphragm globe valves, and other biomedical products, alongside professional medical pumps. These advanced solutions are widely applied across diverse industries, including pharmaceuticals, chemicals, food processing, additive manufacturing, power generation, and other industrial fields.